Similar protective effects, through activation of Nrf2 signaling in DSS-induced colitis in mice, were described for luteolin, oligonol, and sinomenine, which were able to activate also the Nrf2-downstream partner NQO-1 [77,78,79]. Here, NFE2L2 is linked to colitis.